Atlanta Braves Holdings, Inc. (NASDAQ:BATRA – Get Free Report) major shareholder Gamco Investors, Inc. Et Al sold 800 shares of the firm’s stock in a transaction dated Thursday, September 25th. The stock was sold at an average price of $45.41, for a total value of $36,328.00. Following the sale, the insider owned 1,000 shares of the company’s stock, valued at $45,410. The trade was a 44.44% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Large shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.
Gamco Investors, Inc. Et Al also recently made the following trade(s):
- On Friday, September 26th, Gamco Investors, Inc. Et Al sold 500 shares of Atlanta Braves stock. The shares were sold at an average price of $45.51, for a total value of $22,755.00.
- On Friday, September 19th, Gamco Investors, Inc. Et Al sold 1,100 shares of Atlanta Braves stock. The stock was sold at an average price of $45.19, for a total transaction of $49,709.00.
- On Thursday, September 18th, Gamco Investors, Inc. Et Al sold 800 shares of Atlanta Braves stock. The shares were sold at an average price of $45.49, for a total transaction of $36,392.00.
Atlanta Braves Stock Down 0.5%
Atlanta Braves stock opened at $45.30 on Monday. Atlanta Braves Holdings, Inc. has a twelve month low of $38.67 and a twelve month high of $50.50. The company has a debt-to-equity ratio of 1.31, a quick ratio of 0.64 and a current ratio of 0.64. The firm has a market cap of $2.84 billion, a PE ratio of -129.43 and a beta of 0.68. The firm’s 50 day moving average price is $46.86 and its two-hundred day moving average price is $45.51.
Wall Street Analyst Weigh In
Separately, Citigroup began coverage on Atlanta Braves in a research note on Friday, June 13th. They set a “neutral” rating and a $45.00 price target for the company. One analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $52.50.
View Our Latest Report on BATRA
Institutional Investors Weigh In On Atlanta Braves
A number of large investors have recently bought and sold shares of BATRA. PNC Financial Services Group Inc. lifted its holdings in shares of Atlanta Braves by 9.8% during the second quarter. PNC Financial Services Group Inc. now owns 2,507 shares of the financial services provider’s stock worth $123,000 after buying an additional 224 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Atlanta Braves by 4.0% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 6,061 shares of the financial services provider’s stock worth $266,000 after acquiring an additional 234 shares during the period. GAMMA Investing LLC raised its stake in Atlanta Braves by 25.1% during the 1st quarter. GAMMA Investing LLC now owns 1,207 shares of the financial services provider’s stock valued at $53,000 after purchasing an additional 242 shares during the last quarter. MAI Capital Management boosted its holdings in Atlanta Braves by 5.4% in the 1st quarter. MAI Capital Management now owns 5,384 shares of the financial services provider’s stock valued at $236,000 after purchasing an additional 275 shares during the period. Finally, DAVENPORT & Co LLC grew its position in Atlanta Braves by 2.9% in the 2nd quarter. DAVENPORT & Co LLC now owns 11,425 shares of the financial services provider’s stock worth $562,000 after purchasing an additional 325 shares during the last quarter. 12.31% of the stock is currently owned by institutional investors.
Atlanta Braves Company Profile
Atlanta Braves Holdings, Inc owns and operates the Atlanta Braves Major league baseball club. It also operates mixed-use development project, including retail, office, hotel, and entertainment projects. The company was incorporated in 2022 and is based in Englewood, Colorado.
Read More
- Five stocks we like better than Atlanta Braves
- Top Biotech Stocks: Exploring Innovation Opportunities
- SoundHound Breaks Critical Resistance: How High Can It Get Now?
- Overbought Stocks Explained: Should You Trade Them?
- Klarna IPO: BNPL Stock or Something Bigger?
- 3 Healthcare Dividend Stocks to Buy
- Why Teradyne Is a Core Play in the AI Hardware Boom
Receive News & Ratings for Atlanta Braves Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atlanta Braves and related companies with MarketBeat.com's FREE daily email newsletter.